These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31823345)

  • 1. Robustness of ANCOVA in randomized trials with unequal randomization.
    Bartlett JW
    Biometrics; 2020 Sep; 76(3):1036-1038. PubMed ID: 31823345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of covariance in randomized trials: More precision and valid confidence intervals, without model assumptions.
    Wang B; Ogburn EL; Rosenblum M
    Biometrics; 2019 Dec; 75(4):1391-1400. PubMed ID: 31009064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of covariance with pre-treatment measurements in randomized trials: comparison of equal and unequal slopes.
    Funatogawa I; Funatogawa T
    Biom J; 2011 Sep; 53(5):810-21. PubMed ID: 21887795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Robustness of response-adaptive randomization.
    Ye X; Hu F; Ma W
    Biometrics; 2024 Mar; 80(2):. PubMed ID: 38819309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of covariance with pre-treatment measurements in randomized trials under the cases that covariances and post-treatment variances differ between groups.
    Funatogawa T; Funatogawa I; Shyr Y
    Biom J; 2011 May; 53(3):512-24. PubMed ID: 22223254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rejoinder to "Robustness of ANCOVA in randomized trials with unequal randomization" by Jonathan W. Bartlett.
    Wang B; Ogburn EL; Rosenblum M
    Biometrics; 2020 Sep; 76(3):1039. PubMed ID: 31823349
    [No Abstract]   [Full Text] [Related]  

  • 7. Improving the mixed model for repeated measures to robustly increase precision in randomized trials.
    Wang B; Du Y
    Int J Biostat; 2023 Nov; ():. PubMed ID: 38016707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression analysis for covariate-adaptive randomization: A robust and efficient inference perspective.
    Ma W; Tu F; Liu H
    Stat Med; 2022 Dec; 41(29):5645-5661. PubMed ID: 36134688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analyzing pre-post randomized studies with one post-randomization score using repeated measures and ANCOVA models.
    Wan F
    Stat Methods Med Res; 2019; 28(10-11):2952-2974. PubMed ID: 30084297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maintaining the validity of inference from linear mixed models in stepped-wedge cluster randomized trials under misspecified random-effects structures.
    Ouyang Y; Taljaard M; Forbes AB; Li F
    Stat Methods Med Res; 2024 May; ():9622802241248382. PubMed ID: 38807552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preserving the allocation ratio at every allocation with biased coin randomization and minimization in studies with unequal allocation.
    Kuznetsova OM; Tymofyeyev Y
    Stat Med; 2012 Apr; 31(8):701-23. PubMed ID: 22161821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of covariate adjustment approaches under model misspecification in individually randomized trials.
    Tackney MS; Morris T; White I; Leyrat C; Diaz-Ordaz K; Williamson E
    Trials; 2023 Jan; 24(1):14. PubMed ID: 36609282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized clinical trials with a pre- and a post-treatment measurement: repeated measures versus ANCOVA models.
    Winkens B; van Breukelen GJ; Schouten HJ; Berger MP
    Contemp Clin Trials; 2007 Nov; 28(6):713-9. PubMed ID: 17524958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analyzing pre-post designs using the analysis of covariance models with and without the interaction term in a heterogeneous study population.
    Wan F
    Stat Methods Med Res; 2020 Jan; 29(1):189-204. PubMed ID: 30757963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity of tests under covariate-adaptive biased coin randomization and generalized linear models.
    Shao J; Yu X
    Biometrics; 2013 Dec; 69(4):960-9. PubMed ID: 23848580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propensity score weighting for covariate adjustment in randomized clinical trials.
    Zeng S; Li F; Wang R; Li F
    Stat Med; 2021 Feb; 40(4):842-858. PubMed ID: 33174296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal analysis of pre- and post-treatment measurements with equal baseline assumptions in randomized trials.
    Funatogawa I; Funatogawa T
    Biom J; 2020 Mar; 62(2):350-360. PubMed ID: 31394012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic randomization and a randomization model for clinical trials data.
    Kaiser LD
    Stat Med; 2012 Dec; 31(29):3858-73. PubMed ID: 22763807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leveraging prognostic baseline variables to gain precision in randomized trials.
    Colantuoni E; Rosenblum M
    Stat Med; 2015 Aug; 34(18):2602-17. PubMed ID: 25872751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Covariate adjustment and estimation of difference in proportions in randomized clinical trials.
    Liu J; Xi D
    Pharm Stat; 2024 May; ():. PubMed ID: 38763917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.